Kardigan (KARD) director linked fund converts preferred to 13.8M shares, gets RSU grant
Rhea-AI Filing Summary
Kardigan, Inc. director and 10% owner Paul L. Berns reported equity acquisitions tied to Kardigan’s initial public offering and a new board grant. He received 20,706 shares of Common Stock at no cost as a restricted stock unit award, with all RSUs vesting on June 17, 2028, subject to continuous service.
In connection with the IPO, ARCH Venture Fund XIII, L.P., an investment fund associated with Berns, converted its Series A, Series B and Series B-1 Preferred Stock into 13,792,035 shares of Common Stock on a 1.5928-for-1 basis, automatically and without payment of consideration. These shares are held by ARCH XIII, with related general partners and committee members, including Berns, potentially deemed beneficial owners subject to pecuniary-interest limitations.
Positive
- None.
Negative
- None.
Insights
Routine IPO conversions plus a standard director RSU grant.
The activity combines an automatic conversion of preferred stock into common shares at Kardigan’s IPO and a time-based director equity award. No open-market buying or selling occurred, so this is largely structural rather than a trading signal.
ARCH Venture Fund XIII converted its Series A, B and B-1 preferred holdings into 13,792,035 common shares at a fixed 1.5928-for-1 ratio, with no cash changing hands. This simply shifts the capital structure from private preferred to public common stock.
Berns also received 20,706 RSUs that vest in full on June 17, 2028 if he remains in continuous service, aligning his compensation with long-term company performance. Overall, the filing reflects standard pre-IPO to post-IPO capital restructuring and board compensation mechanics.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Conversion | Series A Preferred Stock | 5,148,587 | $0.00 | $0.00 |
| Conversion | Series B Preferred Stock | 1,204,000 | $0.00 | $0.00 |
| Conversion | Series B-1 Preferred Stock | 2,306,401 | $0.00 | $0.00 |
| Conversion | Common Stock | 13,792,035 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 20,706 | $0.00 | $0.00 |
Footnotes (3)
- F1. Each share of Series A Preferred Stock, Series B Preferred Stock and Series B-1 Preferred Stock (collectively, the "Preferred Stock") automatically converted into the number of shares shown in Column 7 on a 1.5928 for 1 basis upon the effectiveness of the Issuer's registration statement on Form S-1 relating to its initial public offering on June 17, 2026 and without payment of consideration. The Preferred Stock had no expiration date.
- F2. These securities are directly held by ARCH Venture Fund XIII, L.P. ("ARCH XIII"). ARCH Venture Partners XIII, L.P. ("AVP XIII LP") is the general partner of ARCH XIII. ARCH Venture Partners XIII, LLC ("AVP XIII LLC") is the general partner of AVP XIII LP. Paul Berns, Kristina M. Burow, Keith Crandell, Steven Gillis and Robert Nelsen are members of the investment committee of AVP XIII LLC (the "AVP XIII LLC Committee Members"). Each of AVP XIII LP and AVP XIII LLC may be deemed to beneficially own the shares held by ARCH XIII, and each of the AVP XIII LLC Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH XIII. Each of AVP XIII LP, AVP XIII LLC and the AVP XIII LLC Committee Members disclaims beneficial ownership except to the extent of their pecuniary interest therein, if any.
- F3. Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on June 17, 2028, subject to the Reporting Person's continuous service as of the applicable vesting date.
Key Figures
Key Terms
restricted stock unit ("RSU") financial
Conversion of derivative security financial
initial public offering financial
beneficial ownership financial
registration statement on Form S-1 regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.